China's share of the world's 10% top-cited publications in Biochemistry, Genetics, and Molecular Biology is projected to decline from 8.6% in 2024 to 7.75% in 2028. This marks a year-on-year decrease of approximately 3.37% in 2025, 2.77% in 2026, 2.23% in 2027, and 1.9% in 2028. The Compound Annual Growth Rate (CAGR) over the forecasted period (2024-2028) suggests an average decrease of 2.52% annually from the 2023 level. This downward trend may indicate competitive pressures and the need for strategic improvements in research output quality.
Future trends to watch for:
- Potential shifts in global research funding allocations.
- Evolving international collaborations and partnerships.
- Advancements in emerging biochemistry and molecular biology fields.
